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There is no sincerer love than the love of food. 
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BAX~ BCL2-associated X protein,BBB ~blood–brain barrier, BMI~ Body Mass Index, CCK ~ 
cholecystokinin, CNS ~ Central Nervous System, DAG ~ diacylglycerol, DAPI~ 4',6-diamidino-
2-phenylindole, DEPC~ Diethylpyrocarbonate, DGKG ~ diacylglycerol kinase gamma, DIG~ 
digoxigenin, ERK ~ extracellular-signal-regulated kinase, ETV5~ Ets variant gene 5, FTO ~ fat 
mass and obesity associated, GLP-1~ glucagon-like-peptide-1, GWAS~ Genome-Wide 
Association Studies, LEPR~ Leptin Receptor, MTCH2~ mitochondrial carrier homolog 2, 
Nudix~ Nucleoside Diphosphate Linked Moiety X, NUDT3~ nucleoside diphosphate linked 
moiety X-type motif 3 gene, PA ~ phosphatidic acid , PBS~ Phosphate-buffered saline, PBT~ 
PBS with 0,5% Triton X-100, PFA~ Paraformaldeyde, POMC~ proopiomelanocortin, PYY3-36~ 
peptide YY3-36, RT~ Room Temperature, SFA ~ subcutaneous fat area , SNP~ Single 
Nucleotide Polymorphism, SSC~ Saline-Sodium Citrate, tBID ~ truncated BID, TBS~ Tris-
Buffered Saline Nudix, TBST~ TBS with 0,1% Tween-20, ZDF~ Zucker diabetic fatty, ZL ~ 
Zucker lean  
Abstract (English/Greek) 
During the recent years the heritability of obesity has been given a lot of focus. Large scale 
genome wide association studies (GWAS) have identified a number of single nucleotide 
polymorphisms (SNPs) found to be associated with variations of Body Mass Index (ΒΜΙ) 
among the population. Four of the genes close to such polymorphisms are Etv5, Nudt3, 
Mtch2 and Sh2b1. As the central nervous system is a major component in food intake 
behavior, in situ hybridization experiments were conducted in order to map the expression 
of the genes in the brain. The results revealed high expression of the genes in food reward 
related regions such as the ventral tegmental area (VTA), the nucleus accumbens (Acb), and 
the amygdala (Amy), as well as in energy homeostasis related regions like the arcuate, 
paraventricular and ventromedial hypothalamic nuclei (Arc, Pa, VMH), suggesting a possible 
role in food intake behavior through food reward system and energy balance.   
 
Τα τελευταία χρόνια έχει δοθεί μεγάλη έμφαση στην κληρονομικότητα της παχυσαρκίας. 
Mελέτες συσχέτισης του γονιδιώματος (GWAS) μεγάλης κλίμακας ταυτοποίησαν έναν 
αριθμό μονονουκλεοτιδικών πολυμορφισμών (SNPs) οι οποίοι βρέθηκε ότι σχετίζονται με 
παρεκκλίσεις του δείκτη μάζας σώματος (ΒΜΙ) μεταξύ του πληθυσμού. Τα γονίδια Etv5, 
Nudt3, Mtch2 και Sh2b1 βρίσκονται κοντά σε τέτοιου είδους πολυμορφισμούς. Καθώς το 
κεντρικό νευρικό σύστημα αποτελεί σημαντική συνιστώσα για τη συμπεριφορά πρόσληψης 
της τροφής, διεξήχθησαν πειράματα in situ υβριδοποίησης με στόχο τη χαρτογράφηση της 
έκφρασης των γονιδίων στον εγκέφαλο. Τα αποτελέσματα έδειξαν υψηλή έκφραση των 
γονιδίων σε περιοχές που σχετίζονται με την επιβραβευτική τροφή, όπως το κοιλιακό 
καλυπτρικό πεδίο (VTA), ο επικληνής πυρήνας (Acb), και τα αμύγδαλα (Amy), καθώς και σε 
περιοχές σχετιζόμενες με την ενεργειακή ομοιόσταση, όπως ο τοξοειδής, ο παρακοιλιακός, 
και ο έσω κοιλιακός πυρήνας του υποθαλάμου (Arc, Pa, VMH), προτείνοντας ένα πιθανό 
ρόλο στη συμπεριφορά πρόσληψης τροφής μέσω του συστήματος επιβράβευσης και της 
ενεργειακής ισορροπίας. 
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Due to the increasing wealth in western societies, palatable food availability has increased 
tremendously and a more sedentary lifestyle has been adopted. Coinciding with these 
changes, the prevalence of obesity has increased rapidly. In 2009-2010 more than one third 
of U.S. adults and almost 17% of U.S. youth were obese (Ogden, Carroll et al. 2012). 
Obesity is an important cause of morbidity and mortality, as well as reduced life expectancy 
in developed world. Every year at least 2,8 million people die as a result of being overweight 
or obese (World Health Organization 2013). There is evidence that it is a risk factor for 
diabetes type II, cardiovascular diseases, some cancer types (colon, breast endometrial and 
gallbladder cancer), osteoporosis, osteoarthritis and other diseases(Goran, Ball et al. 2003, 
Lahmann, Hoffmann et al. 2004, Friedenreich, Cust et al. 2007, Larsson and Wolk 2007, 
Larsson and Wolk 2007, Grazio and Balen 2009, Migliaccio, Greco et al. 2011).  
The crucial question is what causes obesity. That is not an easy question to answer, as the 
underlying mechanisms are difficult to be completely clarified. In overall, obesity is caused 
by perturbations of the balance between food intake and energy expenditure (Obesity: 
Prevention and Treatment, James M. Rippe, Theodore J. Angelopoulos, CRC Press). This 
balance is regulated by a complex physiological system that demands the integration of 
sundry peripheral signals and central coordination in the brain (Obesity: Prevention and 
Treatment, James M. Rippe, Theodore J. Angelopoulos, CRC Press).  
Obesity is a polygenic disease, even if there are exceptions where it is caused by single 
mutations in genes encoding  leptin,  leptin receptor (LEPR), prohormone convertase 1 and 
proopiomelanocortin (POMC), or syndromic forms of it, such as Prader-Willi syndrome 
(Jackson, Creemers et al. 1997, Montague, Farooqi et al. 1997, Clement, Vaisse et al. 1998, 
Krude, Biebermann et al. 1998, Delrue and Michaud 2004). Through large-scale Genome-
Wide Association Studies (GWAS), a number of single nucleotide polymorphisms (SNPs) in 
loci that are correlated with increased BMI and obesity have been identified. Several of 
these likely causal variants in the associated regions are highly expressed or act in the 
central nervous system (CNS), but how they regulate obesity is still obscure (Herrera, 
Keildson et al. 2011). Our target was to map the expression of some of these genes through 
in situ hybridization in mice brain, trying to elucidate their functional role.  
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Figure 1. World-wide obesity prevalence according to WHO 
  
Molecular circuits regulating food intake behavior and energy 
homeostasis 
Knowledge of the regulation of food intake and energy homeostasis is a crucial point to the 
understanding of body weight and obesity. Multiple adiposity signals that regulate food 
intake and energy homeostasis exist, while many Central Nervous System (CNS) pathways 
participate in the response to those. 
 Short-term regulation of food intake 
Although several peptides such as ghrelin (Cummings, Purnell et al. 2001) are identified to 
stimulate feeding, there is no unifying explanation for how eating is initiated and the 
perception of hunger. 
Satiety refers to the reduced interest in food after a meal, while satiation is the feeling of 
fullness that causes meal termination. These two responses make sure that eating stops 
before gastric capacity is reached, and that an appropriate length of time passes, so the 
disposition of the ingested nutrients can be allowed before the next meal starts (Davis and 
Smith 1990). Contrary to hunger perception, the molecular circuits of satiety perception, 
involving gastric distention and peptide signals from gastrointestinal tract cells, are quite 
well understood (Cummings and Overduin 2007). 
Gastric distension is sensed by mechanoreceptor neurons in the stomach and the signal is 
transferred to the hindbrain via vagal afferent and spinal sensory nerves (Ritter 2004). Some 
of the satiation/satiety –inducing peptides released from intestinal enteroendocrine cells are 
cholecystokinin (CCK), glucagon-like-peptide-1 (GLP-1), oxyntomodulin, peptide YY3-36 (PYY3-
36), apolipoprotein A-IV, and enterostatin (Cummings and Overduin 2007). Other satiety –
inducing peptides, such as pancreatic polypeptide (Katsuura, Asakawa et al. 2002), 
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glucagon(Geary and Smith 1982), and amylin (Lutz, Del Prete et al. 1994), are released by the 
endocrine pancreas.  
The main anabolic hormones excreted from the periphery are ghrelin and CCK. Ghrelin is an 
acylated peptide secreted from the gastric mucosa that stimulates feeding and is involved in 
feeding initiation (Cummings, Purnell et al. 2001). So, the levels of circulating ghrelin peak 
just before meal onset and decline very quickly after the meal (Cummings and Overduin 
2007). Nevertheless, mice lacking ghrelin do not display altered meal patterns (Wortley, 
Anderson et al. 2004), and that is the reason that the contribution of ghrelin to feeding 
initiation remains vague. CKK is a satiation peptide secreted by the duodenal and jejunal 
mucosa in response to fat and protein consumption, and decreases food intake  rapidly but 
briefly via the activation of vagal afferents (Kissileff, Pi-Sunyer et al. 1981). Meal size is 
increased by interruptions that agitate CCK signaling, showing the physiological role of CCK 
in satiation (Moran, Ameglio et al. 1992). 
Also, peptide YY3-36 (PYY3-36), which is released from the ileal L cells of the gastrointestinal 
tract after the meal, in proportion to the ingested calories, has been shown that reduces 
appetite, food intake, and weight gain (Batterham, Cowley et al. 2002). This is achieved by 
the modulation of the activity of Neuropeptide Y (NPY) and POMC neurons in the arcuate 
nucleus of the hypothalamus (Batterham and Bloom 2003). 
 Long-term regulation of food intake 
Very important regulators of food intake and energy balance are the catabolic hormones 
leptin and insulin.  
Leptin, which is primarily synthesized in the adipocytes of white adipose tissue and its 
circulation is proportional to the body fat mass, plays a crucial role in energy homeostasis by 
informing the brain about energy balance and the status of stored fat(Morton, Cummings et 
al. 2006). Leptin acts as a negative feedback regulator of adiposity in the brain, as it limits fat 
mass by limiting energy intake and reinforcing energy expenditure (Morton, Cummings et al. 
2006). So, reduced leptin signaling leads to increased food intake, positive energy balance 
and fat accumulation (Morton, Cummings et al. 2006). Leptin receptors (LEPR) reside in 
mesolimbic dopaminergic neurons in hypothalamic areas such as the arcuate nucleus (ARC), 
paraventricular nucleus (PVN), lateral hypothalamic area (LHA), dorsomedial and 
ventromedial hypothalamic nuclei (DMH, VMH), and ventral premammillary nuclei (PMv), as 
well as in many extrahypothalamic regions such as the solitary nucleus (NTS), the ventral 
tegmental area, and the periaqueductal gray matter (Figlewicz and Sipols 2010).  
Despite the fact that leptin administration  results in weight loss, the enthousiasm for it as a 
therapeutic approach for obesity  decreased rapidly,  because it was discovered that leptin 
resistance is a very common phenomenon in obese people (Heymsfield, Greenberg et al. 
1999). Leptin resistance is defined by the failure of elevated leptin levels to suppress feeding 
and mediate weight loss. So, fat mass and leptin levels in the circulation are both increased. 
Although the cellular mechanisms triggering leptin insensitivity are not elucidated yet, 
possible causes are the failure of circulating leptin to reach its targets in the brain across the 
blood–brain barrier (BBB) and the inhibition of the intracellular LEPR signaling cascade 
(Munzberg, Bjornholm et al. 2005). 
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Insulin is produced within the β-cells of the islets of Langerhans in pancreas as a response to 
increased blood sugar. The hormone is crucial for the transport of glucose into the cells and 
causes the liver to convert glucose into glycogen for storage.  When stores of glycogen reach 
the maximum level, the raised insulin levels stimulate the conversion of glucose into lipids 
for long-term storage in adipocytes.  Apart from this aspect, insulin also acts in the brain by 
binding on the insulin receptors in the hypothalamic region. Through this interaction the 
brain gets informed about the energy status of the body, and a decrease in food intake is 
stimulated (Begg and Woods 2012). However, when more insulin is required to maintain a 
normal level of blood glucose, we have the condition of insulin resistance. Insulin resistance 
can probably be explained by the decreased insulin receptors in the brain, when the 
circulating insulin is not enough to decrease the appetite as it is supposed to do (Obici, Feng 
et al. 2002). 
 
Figure 2.  Scheme depicting the long term regulation of energy balance by the catabolic 
hormones insulin and leptin. 
Food reward and Palatability 
Over millions of years, a lot of instinct-based behaviors essential for survival have evolved, 
and one of them is the food reward system. In times when the environmental conditions are 
scarce and dangerous, the food reward gives the essential motivation to overcome those 
difficulties, and eat (Berthoud, Zheng et al. 2012).  So, food reward is the process by which 
the consummation of a specific food reinforces behaviors that endorse the acquisition and 
consumption of the food.  Furthermore, palatability is defined as the hedonic value 
associated with food. The palatability of food has an effect on satiation but not on 
subsequent satiety (De Graaf, De Jong et al. 1999). Behavioral experiments on rats have 
shown that rats prefer to stay in places where they have previously gotten rewarding food  
such as human “snacks” high in fat and sugar, than eat normal chow  (Jarosz, Kessler et al. 
2007). Also, it has been reported that rats-models for binge eating endured even foot shock 
in order to get palatable food (Oswald, Murdaugh et al. 2011). So, it is not surprising that 
processed food manufactures struggle to make their products as much palatable and 
rewarding as can be. 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 03:40:38 EET - 137.108.70.7
11 
 
The central nervous system circuits that are involved in food reward are incorporated with 
the circuits regulating energy homeostasis, so as the food-searching  behavior is adapted to 
the energy needs of that time (Figlewicz and Sipols 2010). A region that is a good example of 
that, as it participates in both processes is the lateral hypothalamic area (LHA) ((Hoebel and 
Teitelbaum 1962)/(Powley and Keesey 1970)). Other brain regions that participate in the 
reward system are the ventral tegmental area, substantia nigra, amygdala, nucleus 
accumbens, orbitofrontal cortex, striatum, and insula(Kenny 2011). Food reward is regulated 
by dopamine signaling, while palatability by opioid peptides (Davis, Levitan et al. 2009)). 
Obese humans and rats have showed less striatal D2 receptor availability than those that 
were lean (Volkow, Wang et al. 2008)/(Fetissov, Meguid et al. 2002)), so their striatum 
responded less to palatable food. As a result, they overate in order to balance the lack of 
reward, leading to weight gain (Wang, Volkow et al. 2002).  Also, regular intake of high-fat 
and high-sugar foods leads to downregulation of postsynaptic D2 receptors, decreased D2 
sensitivity, and reduced reward sensitivity in rodents (Johnson and Kenny 2010) showing 
that overeating can lead to a further damage of the striatal responsivity to food. D2 receptor 
mRNA was also downregulated in both the VMH and LHA in obese rats, compared with lean 
rats (Fetissov, Meguid et al. 2002). Finally, when palatable food such as sucrose are 
consumed, an increase in dopamine levels and turnover occurs in the nucleus accumbens 
(Acb) (Hajnal, Smith et al. 2004). The pathway that mediates this increase is the mesolimbic 
dopamine system that originates in the ventral tegmental area (VTA) and projects to the 
nucleus accumbens (Acb). 
Regarding the regulation of palatability by opioids, it has been shown that opioid receptor 
agonists increased the intake of palatable food compared to standard chow in rodents, while 
opioid antagonists decreased it (Olszewski and Levine 2007). 
Βy measurement of positive and negative orofacial expressions when tasting pleasurable or 
aversive stimuli, it has been shown that the nucleus accumbens shell (Acbsh) and ventral 
pallidum are μ-opioid receptor mediated “hotspots” for liking (Pecina and Berridge 2005). 
Indeed, it was demonstrated that nucleus accumbens injection of an opioid receptor 
antagonist transiently suppressed such sucrose-evoked positive hedonic orofacial reactions 
(Shin, Pistell et al. 2010). 
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Figure 3. Comparison of liking and wanting-related regions between mouse and human 
brain. 
Obesity-associated genes from GWAS 
Until just a few years ago, the genetic factors of obesity were widely unknown, except from 
a few forms of monogenic extreme obesity. During the last years, extensive knowledge of 
the human genome contributed to the development of new tools that make the 
simultaneous analysis of thousands of genes easy. Several high-throughput forward 
approaches are used in the effort to unveil the gene networks associated with many 
diseases, including common obesity. Such approach is GWAS, that allows the scanning of the 
entire human genome in an unbiased manner, using statistical methods to establish 
associations between chromosomal loci and a specific phenotype. Thus, GWAS is really 
useful in order to reveal associations between SNPs and different measures of obesity, such 
as increased BMI (Internet source: http://www.nature.com/scitable/topicpage/genome-
wide-association-studies-gwas-and-obesity-752, 4/8/2013). 
The first locus associated with increased BMI that showed strong statistical significance, was 
identified through GWAS in 2007, and mapped to a gene which at the time had unknown 
function. This gene is now known as fat mass and obesity associated (FTO)(Frayling, Timpson 
et al. 2007).  The FTO encodes an mRNA demethylase. High expression of it has been 
observed in distinct nuclei of the hypothalamus, brainstem, and extended amygdala 
(Fredriksson, Hagglund et al. 2008). It has also been suggested that children homozygotes 
for the risk variant rs9939609 of the FTO are prone to impulsivity towards food (Velders, De 
Wit et al. 2012). 
Since the first GWAS report for obesity, an increasing number of loci have been shown to be 
associated with BMI and other measures of obesity or fat distribution. The loci chosen for 
our research are near the genes ETV5, NUDT3, MTCH2, and SH2B1. 
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The SNPs rs7647305 (Thorleifsson, Walters et al. 2009) and rs9816226 (Speliotes, Willer et 
al. 2010), located in introns of the 3rd chromosome, around 7,4 kb upstream of the Ets 
variant gene 5 (ETV5), have been significantly associated with increased BMI. ETV5 is a 
transcription factor that plays a role in development and cancer (Thorleifsson, Walters et al. 
2009). It is widely expressed, mostly in brain and placenta, and plays an important role in the 
pancreatic development through expression in cells proximal to pancreatic 
mesenchyma(Kobberup, Nyeng et al. 2007)). Also, ETV5 knockout mice have been shown to 
be infertile, with complete stem/progenitor spermatogonia loss, probably due to changes in 
the chemokine production (Simon, Ekman et al. 2010).  
rs7647305 is located 30,7 kb downstream of the gene that expresses diacylglycerol kinase 
gamma (DGKG), which phosphorylates diacylglycerol (DAG) to phosphatidic acid (PA) playing 
a critical role in lipid metabolism. DGKG is highly expressed in the retina (Kai, Sakane et al. 
1994) and the cerebellum (Goto, Funayama et al. 1994). The other body tissues express a 
truncated DGKG, lacking 25 aminoacids. Also, rs7647305 is located 178,5 kb upstream of the 
arginine/serine/rich 10 splicing factor (SFRS10) which is implicated in pre-mRNA splicing 
(Tacke, Tohyama et al. 1998). SFRS is predominantly expressed in brain, liver and testis 
(Nayler, Cap et al. 1998). 
During radioactive in situ hybridization experiments on rats, the animals with restricted 
access to food showed 34% significant decrease of ETV5 expression in the ventral tegmental 
area (VTA) and Substantia nigra (SN).  Also , the animals treated with high fat high sugar 
(HFHS) diet showed a significant decrease of ETV5 expression in the arcuate hypothalamic 
nucleus (Arc) and ventromedial hypothalamic nucleus (VMH) (Boender, van Rozen et al. 
2012).  
Also, ETV5 knockout mice have been shown to have reduced body weight compared to wild 
type mice, suggesting that ETV5 provides protection against gain loss (Schlesser, Simon et al. 
2008). Finally, a study conducted on Zucker lean (ZL)  and Zucker diabetic fatty (ZDF) rats 
showed that the highest ETV5 expression was detected in the hypothalamus, suggesting a 
potential role of it in the energy balance regulation. In ZL rats the expression difference 
between hypothalamus and the adipose tissue was significant and in mesenterial fat the 
expression was higher than in kidney fat (p = 0.018). Also, in ZDF rats the hypothalamic 
amount of ETV5 mRNA was significantly bigger than in the kidney fat and subcutaneous fat. 
In mesenterial fat it was significantly higher expressed than in kidney and subcutaneous fat 
(Schmid, Heid et al. 2012). 
 NUDT3 
The SNP rs206936, located in an intron of the 6th chromosome, near nucleoside diphosphate 
linked moiety X-type motif 3 gene (NUDT3) has been significantly associated with increased 
BMI (Speliotes, Willer et al. 2010). NUDT3 is an enzyme (hydrolase) that belongs to the 
Nudix (Nucleoside Diphosphate Linked Moiety X) protein family. Nudix proteins function as 
homeostatic checkpoints at crucial stages in metabolic pathways of nucleoside phosphates, 
providing protection from elevated levels of potentially deleterious intermediates and 
metabolites, that can promote mutations, by catalyzing their hydrolysis (Safrany, Caffrey et 
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al. 1998). So, NUDT3 can be described as a cell cleaning  gene. It has also been demonstrated 
for NUDT3 to act as a negative regulator of the extracellular-signal-regulated kinase 1/2 
(ERK1/2) pathway (Chu, Alapat et al. 2004).  
A current study demonstrated that NUDT3, together with some other Nudix family proteins, 
has in vitro decapping activity in monomethylated and unmethylated capped RNA(Song, Bail 
et al. 2013). Therefore, NUDT3 may be a critical determinant of mRNA decapping and 
stability. 
In a very recent study, it was shown that rs206936 was significantly associated with BMI and 
subcutaneous fat area (SFA) in Japanese women, but not with any metabolic disorders 
(Kitamoto, Kitamoto et al. 2013).  
rs206936 has also been recently associated with ADHD (Albayrak, Putter et al. 2013) and 
melanoma risk (Li, Liang et al. 2013). 
 
 MTCH2 
The SNPs rs10838738 (Willer, Speliotes et al. 2009), rs4752856 - in the linkage disequilibrium 
region of rs10838738-(Renstrom, Payne et al. 2009), and rs3817334 (Speliotes, Willer et al. 
2010), located in introns of the 11th chromosome, near the mitochondrial carrier homolog 2 
(MTCH2) gene have been significantly associated with increased BMI. MTCH2 is a 
mitochondrial membrane protein that appears to lead to mitochondrial depolarization. The 
substrate transported is not known yet (Uniprot). Unlike most family members of the 
mitochondrial carrier family, MTCH2 is located on the outer membrane of the mitochondria.  
It also appears to control the regulation of cell proliferation (Leibowitz-Amit, Tsarfaty et al. 
2006) and apoptosis. In particular, it co-localizes with a protein complex that includes 
apoptosis regulating truncated BID (tBID) and BCL2-associated X protein (BAX), while it is 
essential for tBID recruitment to the mitochondria (Zaltsman, Shachnai et al. 2010).  
Studies showed that carriers of the risk allele rs10838738 consumed less polysaccharides 
(Bauer, Elbers et al. 2009). Moreover, a high expression of MTCH2 was observed in adipose 
tissue. MTCH2 mRNA and protein expression was also raised in isolated fat cells of obese 
women and during adipocyte differentiation (Kulyte, Ryden et al. 2011).  
Also, MTCH2 was more highly expressed in subcutaneous and mesenterial fat of ZDF, than in 
ZL rats, while high expression in the hypothalamus of both animal groups was observed  
(Schmid, Heid et al. 2012). 
Finally, besides rs10838738 SNP, all other SNPs at MTCH2 showed an association with 
endometrial cancer that was consistent with the directions of association with BMI reported 
in previous GWAS (Delahanty, Beeghly-Fadiel et al. 2011). 
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The SNPs rs7498665 (Thorleifsson, Walters et al. 2009) and rs7359397 (Speliotes, Willer et 
al. 2010), located in introns of the 16th chromosome, near the sarcoma homology 2B1 gene 
(SH2B1), have been significantly associated with increased BMI. SH2B adapter protein 1 is a 
cytoplasmic adaptor protein, that binds via its Src homology 2 (SH2) domain to multiple 
proteins, incuding Insulin receptor (Nelms, O'Neill et al. 1999), insulin receptor substrate 1 
(Morris, Cho et al. 2009) and Janus kinase 2 (Rui, Mathews et al. 1997). 
Taking into account the interaction of SH2B1 with the insulin receptor, its substrate, and 
JAK2, the role of SH2B1 in glucose and energy homeostasis is quite reasonable. SH2B1 acts 
as an endogenous insulin sensitizer. By directly binding to insulin receptors and their 
substrates, it promotes insulin receptor catalytic activity and inhibits tyrosine 
dephosphorylation of the substrates (Morris, Cho et al. 2009). Another study has shown that 
SH2B1-null mice were obese, leptin resistant, insulin resistant and glucose intolerant, and 
had hyperlipidemia, hyperphagia and hyperglycemia. Thus, it is really interesting that their 
condition could be reversed by targeted SH2B1 expression in neurons, and also the JAK2-
mediated leptin signaling showed improvement in the hypothalamus (Li, Zhou et al. 2007). 
This fact suggests that the beneficial effects of SH2B1 on obesity, are mediated through the 
CNS, probably by boosting the hypothalamic leptin sensitivity.  It should also be noted, that 
SH2B1 expression is high in the brain, especially the hypothalamus. Moreover, supporting 
the previous evidence, neuron-specific overexpression of SH2B1 dose-dependently 
protected against high-fat diet–induced leptin resistance and obesity (Ren, Zhou et al. 2007). 
In humans, large deletions in SH2B1 have been associated with severe early-onset obesity 
(Bochukova, Huang et al. 2010). Also, rs7498665 is not only associated with increased BMI in 
humans, but also with increased total fat, saturated fat, and monounsaturated fat intake 
(Bauer, Elbers et al. 2009). 
Finally, in a recent study, SH2B1 SNPs and four other SNPs close to it, were analysed for 
association with triglyceride levels using sequential oligogenic linkage analysis routines 
(SOLAR). A stronger signal was observed for rs8045689, a SNP near SH2B1. rs8045689 is  
located in an intron of spinster homolog 1 (SPNS1) which encodes a protein structurally 
similar to a sphingolipid transporter. Sphingolipids are synthesized from fatty acids, and it is 
possible that sphingolipid metabolism disorders may influence triglyceride levels. Moreover, 
an association with triglyceride levels was also discovered for rs4788102, which is also 
located near SH2B1 (Vastermark, Jacobsson et al. 2012).  
Epigenetics of obesity 
Last but not least, even though so many genes are linked to increased BMI, obesity cannot 
always be explained through the genome. So, epigenetic mechanisms also seem to 
contribute in the complex problem of obesity. The most important epigenetic mechanism is 
DNA methylation. During DNA methylation, DNA methyltransferases add a methyl group on 
the cytosines in CpG dinucleotides, inducing a more compact and rigid nucleosome 
structure, not reachable from the transcription factors (Choy, Wei et al. 2010). As a result, 
transcription is prevented, silencing the gene. Through the lack of methylation, or 
demethylation, the gene is “turned on”, normally expressed. So, changes in the methylation 
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pattern can promote the expression of a gene that has typically been silent or silence a gene 
that is usually active (Rhee, Phelan et al. 2012). Generally, the epigenome is highly dynamic, 
changing in response to nutrition, exercise, and aging (Franks and Ling 2010). 
Several studies demonstrate that an obesogenic in utero environment is able to increase the 
risk for obesity. Exposure to excess saturated fat during early development disturbed the 
hypothalamic expression of genes mediating orexigenic and anorexigenic signaling of the 
offspring (Page, Malik et al. 2009) and affected the offspring’s weight/adiposity phenotypes 
(Carmody, Wan et al. 2011). Moreover, the chemical bisphenol A, used in plastic bottles, had 
a hypomethylating effect in a region upstream to Agouti gene of mice, increasing their 
susceptibility in obesity. This effect could be negated by providing the mother with methyl 
donor supplements, like folic acid (Dolinoy, Huang et al. 2007). Also, according to a recent 
cohort, paternal obesity has been associated with epigenetic abnormalities in newborns. The 
Insulin-like growth factor 2 (IGF2) gene was likely to be less methylated in children whose 
fathers were obese, than in children with non-obese fathers (Soubry, Schildkraut et al. 
2013). 
Of course, epigenetic changes can also happen postnatally, due to environmental factors. 
After six months of aerobic exercise, scientists observed differential methylation pattern of 
473,753 CpG sites in adipose tissue from healthy men. The genes whith altered methylation 
pattern include obesity, diabetes and fat storage-related genes (Ronn, Volkov et al. 2013). 
 
What do we aim for? 
The exact function of most of the genes associated with obesity through GWAS is not 
known. The aim of our study is to try to elucidate the function of the chosen genes (Etv5, 
Nudt3, Mtch2, Sh2b1), by mapping their expression in the central nervous system of the 
mouse, via in situ hybridization on mouse brain.  
It is crucial to understand how the genes are expressed in different brain regions and 
neurotransmitter systems, as our ultimate goal is to investigate the molecular circuits 
regulating food intake and food intake preferences. 
Why mice? 
The mouse is the most important mammalian model organism in biomedical research 
nowadays. The main advantage of the mouse as a model organism is its impressive similarity 
to human when it comes to anatomy, physiology, and genetics. Mouse genetic research is 
applicable to human disease, as over 95% of the mouse genome is similar to human 
(Internet source: http://research.jax.org/mousegenetics/advantages/advantages-of-
mouse.html, 1/8/2013). 
Moreover, mice have some unique technological advantages that make them ideal for 
human disease research. Transgenic mice carrying any gene of interest can be created 
through gene transfer technology, while selected genes can be deliberately mutated 
(Internet source: http://genome.wellcome.ac.uk/doc_WTD020804.html, 1/8/2013).  
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Mice are a really convenient tool for the investigation of CNS regulation of food intake, as 
the arrangement of their brain is nearly identical with the human brain (Figure 4), and they 
both use the same neurotransmitters and receptors, the same proteins for synaptic vesicle 
release and recycling, and similar signaling mechanisms. Moreover, humans and mice share 
the same conserved food reward pathway (Internet source: 
http://learn.genetics.utah.edu/content/addiction/genetics/neurobiol.html, 1/8/2013).  
All the leading mouse models for obesity research are Cpefat, Lepob, Leprdb and tub 
(developed at The Jackson Laboratory). We used the C57BL/6J wild type strain (Figure 5), 
which is prone to diet-induced obesity, and so suitable for investigation of the epigenetic 
mechanisms within adipose tissue that underlie diet-induced obesity (Koza, Nikonova et al. 
2006). 
 
Figure 4. Comparative architecture of human and mouse brain. Sideviews of the whole 
brains (up) and coronal sections (down). 
 
Figure 5. Male C57BL/6J mouse 
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Materials and Methods 
The experiments conducted included extensive in situ hybridization of RNA probes for the 
genes of interest on mouse brain tissue. 
Tissue collection and sectioning  
All animal procedures were approved by the local ethical committee in Uppsala and 
followed the guidelines of European Communities Council Directive (C419/12). 
Adult male C57Bl6/J mice (Taconic M&B) were housed in appropriate controlled 
environment (21oC, 12:12 hours Light/Dark Cycle), with ad libitum access to chow and water. 
The mice were anesthetized by intraperitoneally injection with 100 mg/kg pentobarbital 
sodium. Transcardial perfusion was then performed through the left ventricle with 
phosphate-buffered saline (PBS) followed by 4% formaldehyde (HistoLab). The brain was 
excised and kept in 4% formaldehyde overnight. Afterwards, the brain was washed in 0.1 M 
PBS, embedded in 4% agarose and 50 μm sections were cut on a Leica VT1000S vibratome 
(Leica Microsystems, Germany). The sections were preserved in 0.1 M PBS in the 
refrigerator. 
Design and synthesis of RNA probes 
Antisense probes were generated from commercial mouse cDNA clones (BioScience). The 
gene was cloned into a plasmid using standard procedures. The plasmids were purified with 
the Qiagen Plasmid midi kit and linearized with restriction enzyme (Fermentas). The cleaved 
vector was purified with the GeneJet PCR Purification Kit (#K0701, Thermoscientific) and the 
probes were synthesized using 1 μg cleaved vector and 40 U RNA polymerase (Roche) in the 
presence of digoxigenin (DIG) RNA Labeling mix (Roche), transcription buffer (Roche), and 
RNase Inhibitor (RiboLock, Thermoscientific). To remove template DNA, DNase I was used (2 
units, Thermoscientific). Labeled probes were quantified using the NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies) and stored at -32oC. 
 
In situ hybridization  
The bench and all the equipment used were meticulously sprayed surface decontamination 
solution that destroys RNases (Molecular Bio Products), and all the solutions were made 
with RNase free diethylpyrocarbonate (DEPC)-treated water. Sections were washed 3×5 
minutes with PBS with 0.5% Triton X-100 (PBT) at room temperature (RT). The sections were 
bleached with 6% Hydrogen Peroxide (H2O2) (VWR International) diluted in PBT for 15 
minutes, and washed 3×5 minutes with 0.1 M PBT. Then they were permeabilized in 0.5% 
Triton-X-100 in PBT, and washed again 3×5 minutes with 0.1 M PBT. Tissue was digested 
with 20 µg/ml proteinase K (Invitrogen)  solution in PBT for 6 minutes, washed 3×5 minutes 
with PBT, post-fixed with 4% paraformaldehyde (Histolab)  for 20-25 minutes, and washed 
again 3×5 minutes with PBT. Afterwards, sections were pre-hybridized in hybridization 
buffer (50% formamide (Sigma), 5xSSC, 1% SDS, 50 mg/ml yeast transfer RNA (Sigma), 50 
mg/ml heparin, all diluted in PBT) for 2 hours at 58oC. Hybridization buffer was replaced with 
probe diluted in hybridization buffer (1μg/ml, heat-denatured for 5 minutes at 80oC), the 
plate was sealed thoroughly, and sections were left hybridizing over night at 58  oC. 
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Sections were washed 3×30 minutes with wash buffer II (50% formamide (Sigma), 2xSSC, 1% 
SDS, all diluted in PBT), and then 3×30 minutes with wash buffer III (50% formamide (Sigma), 
0.2xSSC, 0.1% Tween-20, all diluted in PBT) at 65 oC. Afterwards, tissue was washed 2×5 
minutes with Tris-Buffered Saline with 0.1% Tween-20 (TBST), and incubated in blocking 
solution (1% blocking reagent, Roche, in TBST) for 2 hours in RT. The blocking solution was 
replaced by the anti-DIG antibody conjucated to alkaline phosphatase (1:5000, Roche) 
diluted in blocking solution, and the slides were left incubating at 4 oC overnight. 
Sections were washed with 2mM levamisole diluted in TBST 5×10 minutes at RT. Then, 
ready-to-use BM Purple AP substrate precipitating (Roche) was added on the sections. The 
plate was covered with tin foil and the sections were left developing for about 2.5 hours at 
37 oC and washed 3×5 minutes with PBS. Three five-minute washes with PBS followed. 
Sections were carefully placed on Superfrost Plus slides (Menzel-Gläser), mounted with 
Mowiol antifade media (33.3% glycerol, 16.7% Mowiol 4–88, 0.02% Thimerosal, and 2% n-
propyl gallate in PBS, all from Sigma Aldrich) and covered with glass cover slips. 
Pictures of the slides were taken with the MIRAX MIDI slide scanner (Zeiss). The software 
used for taking the pictures was Panoramic Scanner (3DHISTECH), and for resizing and 
adjusting them Panoramic Viewer (3DHISTECH) and Adobe Photoshop CS3 were used. 
Results 
CNS expression of mouse Nudt3, Etv5 and Mtch2 in adult male 
C57Bl6/J mice 
Coronal sections were used to screen male adult mouse brains for areas expressing Etv5, 
Nudt3, Mtch2 and Sh2b1 with in situ hybridization. The expression of these genes is 
ubiquitous, but with certain differences between tissues. Generally, expression was 
predominantly found in the cortex, thalamus, hypothalamus, hippocampus and amygdala. 
Although the mRNA expression of the genes was mapped in the whole brain (See Additional 
Folder), we focused on the brain regions that are known to be implicated in feeding and 
feeding behavior. 
Etv5 
In the diencephalon, Etv5 was highly expressed in the anteroventral thalamic nucleus (AV), 
while in the ventral and lateral part of paraventricular hypothalamic nucleus (PaV, PaLM), 
and in the arcuate hypothalamic nucleus (Arc) the Etv5 expression level was medium. In the 
telencephalon, Etv5 was highly expressed in the medial (CeM), lateral (CeL), and capsular 
(CeC) divisions of the central amygdaloid nucleus, as well as in the ventromedial part of the 
lateral amygdaloid nucleus (LaVM). In the anterior and posterior part of the basolateral 
amygdaloid nucleus (BLA, BLP), as well as in the anterior and posterior part of the 
basomedial amygdaloid nucleus (BMA, BMP), medium Etv5 expression level was detected. 
Also, high expression of Etv5 was found in the regions of the intraamygdaloid division of stria 
terminalis (STIA) and the parabrachial pigmented nucleus of the ventral tegmental area 
(VTA). In the core and shell of the accumbens nucleus (Acbc, Acbsh), and in the anterolateral 
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and posteromedial amygdalo-hippocampal area (AHiAL, AHiPM) the Etv5 expression level 
was medium.   
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Figure 6. Etv5 expression in mouse brain. In situ hybridization on free floating sections using 
1 mg probe/ml of DIG-labeled mouse Etv5 probe (purple staining). 50 μm coronal mouse 
brain sections, visualized as overview, or close up pictures. Abbreviations; A. Caudate 
Putamen (CPu), Pyramidal Tract (Py), Field Ca3 Of Hippocampus (CA3), Medial Habenular 
Nucleus (MHb), Anterodorsal Thalamic Nucleus (AD), Ventrolateral Thalamic Nucleus (VL), 
Ventral Anterior Thalamic Nucleus (VA), Ventromedial Thalamic Nucleus (VM), 
Paraventricular Hypothalamic Nucleus Lateral Magnocellular Part (PaLM), Paraventricular 
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Hypothalamic Nucleus Ventral Part (PaV), Caudate Putamen (CPu), Piriform Cortex (Pir), 
Retrochiasmatic Area Lateral Part (RChL), B. Medial Habenular Nucleus (MHb), Anterodorsal 
Thalamic Nucleus (AD), Ventrolateral Thalamic Nucleus (VL), Ventral Anterior Thalamic 
Nucleus (VA), Ventromedial Thalamic Nucleus (VM), C. Dorsal Endopiriform Nucleus (DEn), 
Basolateral Amygdaloid Nucleus Posterior Part (BLP), Basomedial Amygdaloid Nucleus 
Posterior Part (BMP), Amygdalohippocampal Area Posteromedial Part (AHiPM), 
Amygdalohippocampal Area Anterolateral Part (AHiAL), D. Pyramidal Tract (Py), Medial 
Habenular Nucleus (MHb), E. Medial Habenular Nucleus (MHb), F.  Lateral Mammillary 
Nucleus (LM), G. Cerebral Cortex, H. Central Amygdaloid Nucleus Medial Division (CeM), 
Central Amygdaloid Nucleus Lateral Division (CeL), Central Amygdaloid Nucleus Capsular 
Division (CeC), I. Arcuate Hypothalamic Nucleus (Arc), J. Piriform Cortex (Pir), K. Parabrachial 
Pigmented Area (PBP) 
Nudt3  
In the diencephalon, the Nudt3 expression was medium in the posterior, lateral 
magnocellular, and medial parvicellular part of the paraventricular hypothalamic nucleus 
(PaPo, PaLM, PaMP) and in the ventromedial hypothalamic nucleus (VMH). Also, low  Nudt3 
expression was observed in the lateral and dorsomedial part of the arcuate hypothalamic 
nucleus (ArcL, ArcD). Moreover, in the telencephalon, medium Nudt3 expression level was 
observed in the anterior part of the cortical amygdaloid nucleus (ACo), in the anterior and 
posterior part of the basolateral amygdaloid nucleus (BLA, BLP), as well as in the anterior 
and posterior part of the basomedial amygdaloid nucleus (BMA, BMP), and in the 
dorsolateral, ventrolateral and ventromedial  part of the lateral amygdaloid nucleus (LaDL, 
LaVL, LaDM). Also, high expression of Nudt3 was observed in the regions of the 
posteromedial  part of the amygdalo-hippocampal area (AHiPM), the dorsal tier of the 
compact part of substantia nigra, and the  parabrachial pigmented area (PBP)of the Ventral 
Tegmental Area (VTA). 
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  Figure 7. Nudt3 expression in mouse brain. In situ hybridization on free floating section 
using 1 mg probe/ml of DIG-labeled mouse Nudt3 probe (purple staining). 50 μm coronal 
mouse brain sections, visualized as close up pictures. Abbreviations; A. Lateral Septal Nucleus 
Dorsal Part (LSD), Anterodorsal Thalamic Nucleus (AD), Anteroventral Thalamic Nucleus (AV), 
Paraventricular Thalamic Nucleus Anterior Part (PVA), Paratenial Thalamic Nucleus (PT), 
Central Medial Thalamic Nucleus  (CM), Paraventricular Hypothalamic Nucleus Anterior 
Parvicellular Part (PaAP), Anterior Cortical Amygdaloid Nucleus (ACo), Supraoptic 
Decussation (sox), B. Lateral Amygdaloid Nucleus Dorsolateral Part (LaDL), Basolateral, 
Basolateral Amygdaloid Nucleus Anterior Part (BLA), Basomedial Amygdaloid Nucleus 
Anterior Part (BMA), piriform cortex (Pir), C. Medial Habenular Nucleus (MHb), Anteroventral 
Thalamic Nucleus Dorsomedial Part (AVDM), Anteroventral Thalamic Nucleus Ventrolateral 
Part (AVVL), D.Ventromedial Hypothalamic Nucleus Dorsomedial Part (VMHDM), Arcuate 
Hypothalamic Nucleus Dorsal Part (ArcD), Arcuate Hypothalamic Nucleus Lateral Part (ArcL), 
E. Pyramidal Tract (Py), Granular Layer Of The Dentate Gyrus (GrDG), Medial Habenular 
Nucleus (MHb,) F. Cerebral Cortex, G. Subfornical Organ (SFO), Paraventricular Hypothalamic 
Nucleus Medial Parvicellular Part (PaMP), Anterior Hypothalamic Area Posterior Part (AHP), 
Anterior Hypothalamic Area Central Part (AHC), Arcuate Hypothalamic Nucleus (Arc), H. 
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Nucleus Of Darkschewitsch (Dk), Interpeduncular Nucleus Caudal Subnucleus (IPC), 
Paranigral Nucleus (PN) 
Mtch2 
In the diencephalon, the Mtch2 expression level was medium in the dorsomedial part of the 
ventromedial hypothalamic nucleus (VMHDM). In the telencephalon, medium Nudt3 
expression was detected   in the anterior part of the basomedial amygdaloid nucleus (BMA). 
Also, medium expression level of Mtch2 was observed in the regions of caudate putamen 
(CPu) and the reticular part of substantia nigra (SNR).  
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Figure 8. Mtch2 expression in mouse brain. In situ hybridization on free floating section 
using 1 mg probe/ml of DIG-labeled mouse Nudt3 probe (purple staining). 50 μm coronal 
mouse brain sections, visualized as overview, or close up pictures. Abbreviations; A. Cingulate 
Cortex Area 2 (Cg2), Indusium Griseum (IG), Dorsal Peduncular Cortex (DP), Lateral Septal 
Nucleus Ventral Part (LSV), Caudate Putamen (CPu), Medial Septal Nucleus (MS), Nucleus Of 
The Vertical Limb Of The Diagonal Band (VDB), Islands Of Calleja Major Island (ICjM), Island 
Of Calleja (ICj), Piriform Cortex (Pir), Ventromedial Posterior Nucleus (VMPO), B. Medial 
Septal Nucleus (MS), Nucleus Of The Vertical Limb Of The Diagonal Band (VDB), Islands Of 
Calleja Major Island (ICjM), C. Cingulate Cortex Area 2 (Cg2), Indusium Griseum (IG), Dorsal 
Peduncular Cortex (DP), Lateral Septal Nucleus Ventral Part (LSV), D. Piriform Cortex (Pir), E. 
Ventromedial Posterior Nucleus (VMPO), F. Cerebral Cortex, G.  Pyramidal Tract (py), 
Granular Layer Of The Dentate Gyrus (GrDG), Paraventricular Thalamic Nucleus (PV), Medial 
Habenular Nucleus (MHb), Lateral Habenular Nucleus (LHb), Lateral Posterior Thalamic 
Nucleus Mediorostral Part  (LPMR), Laterodorsal Thalamic Nucleus Ventrolateral Part (LDVL), 
H. Dorsolateral Periaqueductal Gray  (DLPAG), subbrachial nucleus (SubB), Supraoculomotor 
Cap (Su3C), Supraoculomotor Periaqueductal Gray (Su3), oculomotor nucleus, parvicellular 
part (3PC), Dorsal Raphe Nucleus (DR), I. Lateral septal nucleus, intermediate part (LSI), 
Lateral Septal Nucleus Ventral Part (LSV), Cingulate Cortex Area 2 (Cg2), Indusium Griseum 
(IG) 
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In the diencephalon, Sh2b1 expression level was medium in the arcuate nucleus (Arc). In the 
telencephalon, medium Sh2b1 expression was detected in the anterior cortical amygdaloid 
nucleus (ACo),   the anterior and lateral parts of the basomedial amygdaloid nucleus (BMA, 
BLA), the dorsolateral  and ventrolateral parts of the lateral amygdaloid nucleus (LaDL, LaVL), 
as well as in the , posterodorsal and posteroventral parts of the medial amygdaloid nucleus 
(MePD, MePV). 
 
Institutional Repository - Library & Information Centre - University of Thessaly




Figure 9. Sh2b1 expression in mouse brain. In situ hybridization on free floating section 
using 1 mg probe/ml of DIG-labeled mouse Nudt3 probe (purple staining). 50 μm coronal 
mouse brain sections, visualized as overview, or close up pictures. Abbreviations; A. Granular 
dentate gyrus (GrDG), Pyramidal cell hippocampus (Py), Lateral habenular nucleus (LHb), 
Medial habenular nucleus (MHb), Arcuate Nucleus (Arc), Anterior Cortical Amygdaloid 
Nucleus (ACo), Basomedial amygdaloid nucleus, anterior part (BMA), Basomedial 
amygdaloid nucleus lateral part (BLA), Lateral Amygdaloid Nucleus Dorsolateral Part (LaDL), 
Lateral Amygdaloid Nucleus Ventrolateral Part (LaVL), Medial Amygdaloid Nucleus 
Posterodorsal Part (MePD), Medial Amygdaloid Nucleus Posteroventral Part (MePV), B. 
Arcuate Nucleus (Arc), C. Anterior Cortical Amygdaloid Nucleus (ACo), Basomedial 
amygdaloid nucleus, anterior part (BMA), Basomedial amygdaloid nucleus lateral part (BLA), 
Lateral Amygdaloid Nucleus Dorsolateral Part (LaDL), Lateral Amygdaloid Nucleus 
Ventrolateral Part (LaVL), Medial Amygdaloid Nucleus Posterodorsal Part (MePD), Medial 
Amygdaloid Nucleus Posteroventral Part (MePV) , D. Granular dentate gyrus (GrDG), 
Pyramidal cell hippocampus (Py), Lateral habenular nucleus (LHb), Medial habenular nucleus 
(MHb),  E. Cerebral Cortex, F. Cingulated cortex area 2 (Cg2), Indusium griseum (IG), Lateral 
septal nucleus, dorsal part (LSD), Lateral septal nucleus, ventral part (LSV), G. Dorsal Lateral 
Geniculate Nucleus (DLG), Lateral posterior thalamic nucleus, mediorostral part (LPMR), 
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Lateral Posterior Thalamic Nucleus, Laterorostral Part (LPLR), Granular dentate gyrus (GrDG), 
Pyramidal cell hippocampus (Py), Medial habenular nucleus (MHb) 
DISCUSSION 
The areas and nuclei where the obesity related genes were expressed 
The obesity related genes were expressed in a lot of brain areas and nuclei (see additional 
folder and results), a lot of which have been previously related with obesity.   
 Etv5 expression in the amygdala, the ventral tegmental area and the 
accumbens nucleus strongly suggest the gene’s role in food reward, as those 
regions are reward network components. Also, expression in the 
paraventricular and arcuate hypothalamic nuclei, suggests a probable role of 
Etv5 in energy balance. 
 Nudt3 expression in food-reward network components, like the amygdala 
and the ventral tegmental area, suggest a role of it in food reward. 
Expression in hypothalamic regions that participate in energy-related feeding 
behavior, like the paraventricular and anteroventral thalamic nuclei, suggest 
a role of the gene in energy balance. 
 Mtch2 expression only in the ventromedial hypothalamic nucleus, and in the 
basomedial amygdaloid nucleus, not so strongly suggest a possible role in 
energy intake and food reward, respectively. 
 Finally, Sh2b1 expression in the hypothalamic arcuate nucleus, the most 
important hypothalamic component in energy-associated feeding behavior, 
and in many amygdaloid nuclei, suggests a role of it in energy balance and 
food reward, respectively. 
Moreover, all the genes showed very high expression in the hippocampal formation that has 
been recently associated with food intake, in piriform cortex that participates in the 
olfactory system, in the cerebral and cingulated cortex, and in other brain regions that are 
potentially associated with food intake behavior.  
  
Previous bibliography about the regions where expression was high, and their relation with 
obesity and food intake behavior will be listed, aiming in the elucidation of their function in 
food intake behavior. 
~Hypothalamus 
The arcuate nucleus (Arc) and the ventromedial hypothalamus (VMH) are hypothalamic 
regions that integrate peripheral metabolic signals and receive input from multiple other 
metabolic centers in the brain. The Arc includes two neuronal populations with different 
functional roles. One population is orexigenic and expresses neuropeptide Y and AGRP 
(agouti-related protein), while the other is anorexigenic and expresses POMC and CART 
(cocaine- and amphetamine-regulated transcript) (Garfield, Lam et al. 2009). So, energy 
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sufficiency leads to low NPY/AgRP expression and high POMC/CART expression in the Arc, 
which promote satiety (Ziotopoulou, Mantzoros et al. 2000) while energy lack results in high 
NPY/AgRP expression and low POMC/CART expression that promote hunger (Pinto, 
Roseberry et al. 2004). VMH is described as the satiety center. Lesions in the VMH led rats to 
overeating and obesity, while electrical stimulation of it led to increased satiety as the 
animals stopped eating (Treatment of the Obese Patient (Contemporary Endocrinology), 
Robert F. Kushner, Daniel H. Bessesen, page 4). 
Paraventricular hypothalamic nucleus is known to be involved in hunger regulation. Lesions  
of the nucleus led to increased meal size in rat experiments(Shor-Posner, Azar et al. 1985). 
Also, paraventricular hypothalamic nucleus, as well as arcuate nucleus, ventromedial 
hypothalamic nucleus, and lateral hypothalamic area are regions where a lot of leptin 
receptors are, explaining their effect on energy balance (Guyenet and Schwartz 2012). 
~Ventral Tegmental Area-Nucleus Accumbens-Substantia Nigra 
Contrary to the hypothalamic centers that control homeostatic feeding, the substantia nigra 
(SN) and the ventral tegmental area (VTA) are regions related with motivation for food, as 
they are the sole sources of striatal and limbic forebrain dopamine (Zhou and Palmiter 
1995). In the VTA and SN extensive co-expression of insulin and leptin receptors with a 
dopamine neuron marker, suggesting that midbrain dopamine neurons are direct targets of 
insulin and leptin, participating in the mediation of the effects of these hormones on 
reward-seeking behavior (Figlewicz, Evans et al. 2003). 
As previously mentioned (See Introduction-Food reward and palatability), the nucleus 
accumbens plays a crucial role in food reward and palatability mediated by dopamine and 
opioids, respectively. Also, it has been discovered that GLP-1 release in accumbens nucleus 
of rats reduces the hedonic value of food, as antagonists of the GLP-1 receptors have been 
shown to increase meals size and palatability in rats (Dossat, Diaz et al. 2013). 
~Amygdala 
Generally, the amygdala are known for their role in memory processing and emotions, 
especially fear and stress. With regard to food, the amygdala are implicated in food reward, 
detecting the flavor intensity and palatability of a certain food and inducing the desire to eat 
more. As a result, amydgala are strongly associated with obesity and food intake behavior 
(Yale Scientific 2012).  
During electrophysiology experiments in rats, it was shown that the central amygdaloid 
nucleus influences gut-associated neurons in the dorsal vagal complex. After electrical 
stimulation of the nucleus, altered basal firing rates in the gut-associated neurons of the 
solitary tract and dorsal motor nucleus of the vagus were observed, as well as modulated 
neuronal response to gastrointestinal stimuli in the dorsal vagal complex. This neuronal 
circuitry seems to explain how gastrointestinal activity is regulated by the amygdala (Zhang, 
Cui et al. 2003) 
Moreover, in situ hybridization experiments revealed the presence of ghrelin receptor mRNA 
in several amygdaloid nuclei, with the highest levels of expression in the ventrolateral (LaVL) 
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and ventromedial (LaVM) parts of the lateral amygdaloid nucleus (Alvarez-Crespo, Skibicka 
et al. 2012). 
Melanin-concentrating hormone (MCH) is an orexigenic peptide involved in food intake 
behavior, controlling both short and long term food intake in rats (Della-Zuana, Presse et al. 
2002). Neurons containing MCH are mostly located in the lateral hypothalamic area (LHA). In 
a recent study, it was shown that neurons of the anterior part of  basomedial amygdaloid 
nucleus (BMA) and the anterior cortical amygdaloid nucleus (CoA) innervate MCH neurons in 
the LHA, suggesting that this pathway may have a role in food intake (Niu, Yokota et al. 
2012). LHA is characterized as hunger center. Lesions in the LHA of rats have resulted in loss 
of interest in food, and decreased body weight. When the LHA was electrically stimulated, it 
caused eating in satiated animals (Treatment of the Obese Patient (Contemporary 
Endocrinology), Robert F. Kushner (Editor), Daniel H. Bessesen, page 4). 
Corticotropin-releasing factor type 1 (CRF1) receptor antagonists, having the ability to reduce 
the motivational effects of withdrawal, have been proposed as novel therapeutic targets for 
addictive disorders. As palatable food intake is closely related to addiction, scientists 
investigated whether CRF1 receptors in the basolateral (BLA) and central (CeA) amygdaloid 
nucleus can mediate excessive eating of palatable food in diet cycled rats. One rat group had 
ad libitum access to a chow diet 7 days a week (Chow/Chow, control group), and the other 
had free access to chow for 5 days a week, followed by 2 days of ad libitum acces to a highly 
palatable, chocolate-flavored, high-sucrose diet (Chow/Palatable group). Microinfusion of 
the CRF1 receptor antagonist R121919 into the BLA reduced the hypophagia of regular chow 
diet in Chow/Palatable rats, without affecting it in Chow/Chow rats. On the other hand, 
intra-CeA R121919 completely blocked the excessive eating of palatable food in 
Chow/Palatable rats, without affecting regular chow intake in control Chow/Chow rats (left 
panel). These results indicate that the CRF–CRF1 receptor system in the CeA is a key 
mediator of excessive eating of palatable food and the withdrawal-dependent negative 
affect, whereas in the BLA it mediates the subjects’ aversive responses induced by reward 
reduction (Iemolo, Blasio et al. 2013). 
As serotonin and the medial amygdaloid nucleus (MeA) has been known as two components 
critical in food intake regulation, scientists examined the effects of the serotonin reuptake 
inhibitor, zimelidine, on rat feeding behaviour in order to investigate the serotonergic 
system in the MeA. Zimelidine microinjection into the MeA provoked dose dependent 
hypophagic effects in fasted rats, while microinjection of a 5-HT(2C) receptor antagonist 
blocked this hypophagic effect, suggesting the role of MeA 5-HT(2C) receptors in the 
modulation of  the hypophagic effect caused by zimelidine (Scopinho, Fortaleza et al. 2012).  
Finally, when naloxone  was infused into the ventral pallidum or nucleus accumbens shell, 
and food deprivation was induced, changes in sucrose palatability were blocked, and 
incentive learning was not affected. On the other hand, naloxone infusion into the 
basolateral amygdala blocked incentive learning and did not affect sucrose palatability. 
These changes in palatability and incentive learning regulated by opioids suggest the 
complex role of endogenous opioids in reward system, and show the role of these regions to 
neural processes that rule rewarding events and desire (Wassum, Ostlund et al. 2009).  
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The ventrolateral thalamic nucleus has been shown to play a crucial role in the learning of 
performing tasks that require coordination and planning of movement (Subcortical 
Functions in Language and Memory, Bruce A. Crosson). This could be a component in food 
reward behavior, as many times the acquisition of the desired food requires the 
performance of a specific motor task, such us the pressing of a lever (Sharma, Hryhorczuk et 
al. 2012). 
The anterodorsal and anteroventral thalamic nuclei might not be directly associated with 
food intake, but they have a crucial role in spatial memory (van Groen, Kadish et al. 2002). 
Since spatial memory is important in food reward behaviour (a good example are the rats 
remembering the place where they got palatable food (Jarosz, Kessler et al. 2007) ), the 
expression of the genes in those nuclei might show their involvement in food reward. 
~Piriform Cortex 
Apart from taste, touch, temperature and texture, the smell and the appearance of food 
contribute to the whole picture of palatability. The piriform cortex (Pir) is a basic component 
of the olfactory system, the sensory system used for smell (Kenny 2011). It has been 
suggested that the anterior piriform cortex plays a role in neuroperception of deficiencies or 
imbalances in physiologically essential amino acids. Diets deficient in aminoacids has been 
shown to induce the expression of c-fos in the anterior piriform cortex (Cummings 1997).  
~Hippocampus 
The hippocampus, a brain structure involved in learning, memory, and spatial navigation, 
has recently been associated with food intake control. Leptin administration to the ventral 
hippocampus suppressed food intake, body weight and memory consolidation for the spatial 
location of food. So, ventral hippocampal leptin signaling seems to contribute to the 
inhibition of food-related memories provoked by coherent stimuli (Kanoski, Hayes et al. 
2011). 
~Cerebral cortex-cingulate cortex 
Scientists investigated that there was an increase in the binding of CCK to its receptors in the 
cerebral cortex of ob/ob mice, due to an increase of the receptor sites, suggesting that CCK 
binding and action in specific regions may be associated with obesity (Saito, Williams et al. 
1981). Also, a neuronal representation of taste is found in the cingulate cortex, which is 
activated by many pleasant stimuli, suggesting the role of it in motivation and emotion (Rolls 
2008). 
~Caudate Putamen 
Restoration of dopamine production within the caudate putamen of hypophagic dopamine-
deficient mice restored their feeding on regular chow, suggesting a role in food intake 
behavior for the region (Szczypka, Kwok et al. 2001).  
How the obesity-associated SNPs act on the expression of the nearby 
genes? Possible mechanisms 
The obesity-associated SNPs of interest are located in introns near the genes on which we 
did research. Even if introns are removed through splicing, and their sequence does not 
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participate in the transcript, it is sure that they can affect gene expression. This is obvious 
from the fact that intronless and intron-containg versions of the same gene have shown 
different expression profile. Moreover, introns have been shown to be extremely crucial in 
transgene expression. By the addition of just one intron in transgenic mice the efficiency of 
transcription could dramatically increase up to 100 times (Brinster, Allen et al. 1988). The 
possible mechanisms of intron function are several. First of all, introns are important for 
efficient splicing. Also, elements that regulate the transcription, such as repressors and 
enhancers, can be binded on binding sites that are located in introns. So, a difference in the 
sequence of a transcriptional regulatory element could dramatically effect the extent of 
gene expression. Moreover, it has been shown that splicing signals can enhance the action 
of RNA polymerase, enhancing transcription level (Furger, O'Sullivan et al. 2002). When it 
comes to pre-mRNA processing events, on the one hand, the nuclear cap-binding complex 
promotes the excision of the 5′-most intron (Le Hir, Nott et al. 2003). On the other hand, 3′-
end formation is reciprocally linked to splicing, involving direct contacts between splicing 
and polyadenylation machineries (Proudfoot, Furger et al. 2002). Furthermore, sequences in 
introns are required for the chemical alteration of exonic nucleotides through RNA editing 
(Reenan 2001). Finally, it has been shown that some introns are mobile genetic elements 
(Lambowitz and Belfort 1993). All these possible roles that introns have in the regulation of 
gene expression, can explain why an SNP in a crucial sequence of the intron could lead to big 
expression changes. 
As the obesity-associated SNPs rs7647305 and rs9816226 are located in an intron near ETV5, 
they could probably increase the expression of the ETV5 transcription factor by the 
disturbance of the sequence of a transcriptional regulatory element binding site in the 
intron. 
Except from their proximity to ETV5, the obesity associated SNPs located in the intron near 
ETV5 are also near genes that encode other proteins. rs7647305, is located in an intron near 
the diacylglycerol kinase gamma, which reverses the normal flow of glycerolipid biosynthesis 
by phosphorylating diacylglycerol back to phosphatidic acid. As diacylglycerol is a precursor 
of triacylglycerol, a decreased expression and action level of diacylglycerol kinase gamma 
will lead to increased triacylglycerol levels. So, one possible mechanism of how rs7647305 
acts is by disturbing the sequence of a DGKG gene suppressor binding site in the intron, and 
decreasing the expression level of DGKG. On the other hand, rs9816226, is located near a 
splicing factor. So, the SNP could probably affect the expression of the splicing factor, 
disturbing splicing. 
The obesity-related SNP rs206936 is located in an intron near NUDT3. As NUDT3 has shown 
in vitro decapping activity in methylated and unmethylated RNA, a possible action 
mechanism of it in obesity is by affecting mRNA decapping and stability. This SNP could 
probably change the sequence of a suppressor or enhancer binding site, changing the extent 
of decapping activity. Increased decapping leads in increased mRNA degradation by 
exonucleases, while decreased decapping results mRNAs with 5΄cap, stable and resistant to 
exonucleases, available for splicing and translation. Interesting is the fact that when the 
body is under nutrient starvation condition, the decapping is stimulated in order to save 
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energy from protein synthesis, and decapping is also promoted when premature stop 
codons are recognized. 
The obesity associated SNPs located in an intron near the MTCH2 gene, could affect the 
expression of the protein through a sequence change in a binding site of a transcriptional 
regulatory element. Since MTCH2 regulates cell proliferation and apoptosis, and obesity is 
associated with increased fat cell renewal (Arner and Spalding 2010), the distorted control of 
fat cell renewal is a possible mechanism by which MTCH2 contributes to obesity (Kulyte, 
Ryden et al. 2011). 
Concerning the SNPs located in an intron near the SH2B1 gene, they could decrease the 
expression of the protein through a sequence change in a binding site of a transcriptional 
regulatory element. A disturbance in the expression of the SH2B1 protein can have 
important effects in energy and glucose homeostasis, as SH2B1 binds insulin receptors and 
their substrates, promoting insulin receptor catalytic activity. 
Finally, all the obesity-associated intron SNPs could cause a splicing site mutation, resulting 
in introns remaining in mature mRNA. Also, the SNPs could affect RNA editing, resulting in 
altered RNA structure, or even degradation. 
 
Ideas for future research 
The results gained from the in situ hybridization experiments are very interesting, as the 
expression of the genes of interest in food intake-related brain areas shows their function in 
food intake behavior and energy balance through CNS. However, in order to gain more 
information about the function of the genes, more different experiments should be 
conducted. Double in situ could allow the co-localization of the mRNA of the genes.  Also, 
immnohistochemistry experiments for the cellular localization of the protein, as well as c-Fos 
immunohistochemistry experiments combined with in situ hybridization for the gene 
compared between feeding termination and feeding initiation, could shed more light to the 
function of the genes. For higher specificity and sensitivity, in situ proximity ligation assay 
(PLA) could be used for the detection of the protein. Moreover, the expression level of the 
genes could be charted through real time PCR. The expression could be charted after 
different  conditions, such as consumption of palatable food or food deprivation. 
Also, since the genes seem to have an expression predominant in the  amygdala and other 
food intake behavior-related brain regions, behavioral studies on wild type and knock out 
mice for the genes would be definitely interesting. Behavioral experiments during which the 
animal has to perform a task in order to obtain a highly palatable food reward (pressing a 
lever to receive the reward, learning a specific route finding its way through a maze) are 
good examples. Also it will be interesting to study the stress-induced eating of palatable 
food, as well as the battle between fear or pain, and palatable food. 
Finally, clinical studies should be conducted on genotyped subjects. Functional magnetic 
resonance imaging (fMRI) of the subjects’ brain at different times could shed more light on 
the expression and function of the polymorphisms. Psychological tests like the Stroop can 
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also contribute to create a more complete picture of how the polymorphisms affect the 
different brain regions.  
The eventual characterization of the obesity-associated gene products will reveal their 
etiological pathways, suggesting them as molecular targets for pharmacological 
interventions that will probably lead to effective treatments. Still, many pieces of the puzzle 
are missing. 
Conclusion 
In conclusion, our data allow as to link those four obesity-associated genes (Etv5, Nudt3, 
Mtch2, Sh2b1) with the regulation of food intake and food intake preferences by the CNS. 
The association of the genes with food reward seems to be stronger than the association 
with homeostatic feeding. Although our results seem to bring us one step closer to finding 
out the function of those genes, further investigation should be conducted in order to 
completely elucidate their functional role. 
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ADDITIONAL FOLDER 
 
-, no apparent expression 
+, low expression 
++, medium expression 
+++, high expression 
The regions are organized in alphabetical order under each subsection. 
 
Etv5 expression  
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Anterodorsal thalamic nucleus (AD) ++ 
Anteromedial thalamic nucleus (AM) ++ 
Anteroventral thalamic nucleus (AV) +++ 
Dorsal lateral geniculate nucleus (DLG) ++ 
Lateral posterior thalamic nucleus , mediorostral part (LPMR)  + 
Laterodorsal thalamic nucleus, dorsomedial part (LDDM) + 
Medial habenular nucleus (MHb) ++ 
Ventrolateral thalamic nucleus, anterior part (VA) +++ 
Ventrolateral thalamic nucleus, lateral part (VL) +++ 
Ventromedial thalamic nucleus, medial part (VM) ++ 
Hypothalamus 
Arcuate hypothalamic nucleus (Arc)++ 
Paraventricular  hypothalamic nucleus, ventral part (PaV) ++ 
Paraventricular Hypothalamic Nucleus, Lateral Magnocellular Part (Palm) ++ 
Telencephalon 
Cerebral cortex 
 Layer 1- 
Layer 2++ 
Layer 3+ 




Basolateral amygdaloid nucleus, anterior part (BLA)++ 
Basolateral amygdaloid nucleus, posterior part (BLP) ++ 
Basomedial amygdaloid nucleus, anterior part (BMA) ++ 
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Basomedial amygdaloid nucleus, posterior part (BMP) ++ 
Central amygdaloid nucleus, capsular division (CeC) +++ 
Central amygdaloid nucleus, lateral division (CeL) +++ 
Central amygdaloid nucleus, medial division (CeM) +++ 
Lateral amygdaloid nucleus, ventromedial part (LaVM) +++ 
Hippocampal formation 
Pyramidal cell hippocampus (Py) +++ 
Granular dentate gyrus (GrDG) + 
Other 
Accumbens nucleus core (Acbc) ++ 
Accumbens nucleus shell (Acbsh) ++ 
Amygdalo-hippocampal area, anterolateral (AHiAL) ++ 
Amygdalo-hippocampal area, posteromedial (AHiPM) ++ 
Caudate putamen (CPu) + 
Dorsal endopyriform nucleus (DEn) +++ 
External capsule (EC) +++ 
Field CA3 hippocampus (CA3) ++ 
Lateral septal nucleus, dorsal part (LSD) ++ 
Lateral septal nucleus, intermediate part (LSI) ++ 
Molecular dentate gyrus (MoDG) + 
Parabrachial pigmented nucleus (PBP) +++ 
Piriform cortex (Pir) ++ 
Retrochiasmatic area (RChL) ++ 
Stria terminalis intraamygdaloid division (STIA) +++ 
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Anterodorsal thalamic nucleus (AD) ++ 
Anteroventral Thalamic Nucleus (AV)  ++ 
Anteroventral Thalamic Nucleus Dorsomedial Part ( AVDM ) ++ 
Anteroventral Thalamic Nucleus Ventrolateral Part ( AVVL ) ++ 
Central medial thalamic nucleus (CM) ++ 
Dorsal lateral geniculate nucleus (DLG) ++ 
Lateral posterior thalamic nucleus, mediocaudal part (LPMC) ++ 
Laterodorsal thalamic nucleus, dorsomedial part (LDDM) + 
Medial habenular nucleus (MHb) ++ 
Parafascicular thalamic nucleus (PF) ++ 
Paraventricular Thalamic Nucleus Anterior Part ( PVA ) ++ 
Ventral posterior thalamic nucleus, parvicellular part (VPPC) ++ 
Ventral posteromedial thalamic nucleus (VPM) ++ 
Hypothalamus 
Anterior Hypothalamic Area, Central Part ( AHC ) + 
Anterior Hypothalamic Area, Posterior Part ( AHP ) +  
Arcuate hypothalamic nucleus (Arc) + 
Arcuate hypothalamic nucleus, dorsomedial part (ArcD) + 
Arcuate hypothalamic nucleus, lateral part (ArcL) + 
Lateral mammillary nucleus  (LM) ++ 
Paraventricular hypothalamic nucleus, lateral magnocellular part (PaLM)  ++ 
Paraventricular Hypothalamic Nucleus, Medial Parvicellular Part ( PaMP ) ++ 
Paraventricular hypothalamic nucleus, posterior part (PaPo) ++ 
Supraoptic nucleus (SO) ++ 
Ventromedial hypothalamic nucleus (VMH) ++ 
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 Layer 1- 
Layer 2++ 
Layer 3++ 




Anterior cortical amygdaloid nucleus (ACo) +++ 
Basolateral amygdaloid nucleus, anterior part (BLA) ++ 
Basolateral amygdaloid nucleus, posterior part (BLP) ++ 
Basomedial amygdaloid nucleus, anterior part (BMA) ++ 
Basomedial amygdaloid nucleus, posterior part (BMP) ++ 
Lateral amygdaloid nucleus, dorsolateral part (LaDL) ++ 
Lateral amygdaloid nucleus, ventrolateral  part (LaVL) ++ 
Lateral amygdaloid nucleus, ventromedial  part (LaDM) ++ 
Medial Amygdaloid Nucleus Posterodorsal Part (MePD) ++ 
Medial Amygdaloid Nucleus Posteroventral Part (MePV) ++ 
Hippocampal formation  
Granular Dentate Gyrus (GrDG) +++ 
Pyramidal cell hippocampus (Py)  +++ 
Other 
Amygdalo-hippocampal area, posteromedial  part (AHiPM) ++ 
Caudate putamen (CPu) + 
Cingulated cortex, area 2 (Cg2) +++ 
Dorsal peduacular cortex (DP)++ 
Dorsal subiculum (DS) +++ 
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Indusium griseum (IG) ++ 
Interfascicular nucleus (IF)+ 
Interpeduncular fossa (IPF) + 
Interstitial nucleus of Cajal (InC) + 
Lambdoid septal zone (Ld) ++ 
Lateral septal nucleus, dorsal part (LSD) ++ 
Medial septal nucleus (MS) ++ 
Nucleus of Darkschewitsch (Dk) + 
Nucleus of posterior commissure (PCom) ++ 
Nucleus of the optic tract (OT) ++  
Nucleus of the vertical limb of the diagonal band (VBD) ++ 
Piriform  Cortex (Pir)+++ 
Paranigral Nucleus (PN) +++ 
Pontine Nuclei (Pn) ++ 
Retromammilary nucleus, lateral part (RML) ++ 
Retromammilary nucleus, medial part (RMM) ++ 
Retrosplenial granular cortex b  (RSGb) +++ 
Retrosplenial granular cortex c (RSGc) +++ 
Supraoptic Decussation (sox) ++ 
Substantia nigra, compact part , dorsal tier (SNCD) ++ 
Ventral tuberomammillary nucleus (VTM) +++ 
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Lateral habenular nucleus (LHb) + 
Lateral posterior thalamic nucleus, mediorostral part (LPMR) ++ 
Laterodorsal thalamic nucleus, ventrolateral (LDVL) ++ 
Medial geniculate nucleus, dorsal part (MGD) ++ 
Medial geniculate nucleus, medial part (MGM) ++ 
Medial geniculate nucleus, ventral part (MGV) ++ 
Medial habenular nucleus (MHb) ++ 
Paraventricular thalamic nucleus (PV) ++ 
Hypothalamus 
Ventromedial hypothalamic nucleus, dorsomedial part (VMHDM) ++ 
Telencephalon 
Cerebral cortex 
 Layer 1- 
Layer 2++ 
Layer 3++ 




Basomedial amygdaloid nucleus, anterior part (BMA) ++ 
Hippocampal formation  
Granular dentate gyrus (GrDG) +++ 
Pyramidal cell hippocampus (Py) +++ 
Other 
Caudate putamen (CpU) + 
Cingulated cortex area 2 (Cg2) ++ 
Dentate gyrus (DG) +++ 
Dorsal peduncular cortex (DP) ++  
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Dorsal raphe nucleus (DR) ++ 
Dorsolateral periaqueductal gray (DLPAG) ++ 
Dorsomedial periaqueductal gray (DMPAG) ++ 
Habenular commissure (hbc) +++ 
Indusium griseum (IG) ++ 
Interpeduncular nucleus, caudal subnucleus (IPC) + 
Interpeduncular nucleus, lateral subnucleus (IPL) + 
Interpeduncular nucleus, rostral subnucleus (IPR) + 
Interpeduncular nucleus, intermediate subnucleus (IPI) + 
Island of Calleja, major island (ICjM) ++ 
Lateral septal nucleus, intermediate part (LSI) ++ 
Lateral septal nucleus, ventral part (LSV) ++ 
Medial septal nucleus (MS) + 
Nucleus of Darkschewitsch (Dk) ++ 
Nucleus of the vertical limb of the diagonal band (VDB) +++ 
Oculomotor nucleus, parvicellular part (3PC) ++ 
Piriform cortex (Pir) +++ 
Pontine nuclei (Pn) ++ 
Red nucleus + 
Subbrachial nucleus (SubB) +++ 
Substantia nigra, reticular part (SNR) + 
Subthalamic nucleus (STh) ++ 
Superior cerebellar penducle (scp) + 
Supraoculomotor  periaqueductal gray (Su3C) ++ 
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Dorsal Lateral Geniculate Nucleus (DLG) ++ 
Lateral habenular nucleus (LHb) + 
Lateral posterior thalamic nucleus, mediorostral part (LPMR) ++ 
Lateral Posterior Thalamic Nucleus, Laterorostral Part (LPLR) ++ 
Medial habenular nucleus (MHb) ++ 
Hypothalamus 
Arcuate Nucleus (Arc) ++ 
Telencephalon 
Cerebral cortex 
 Layer 1- 
Layer 2++ 
Layer 3++ 




Anterior Cortical Amygdaloid Nucleus (ACo)+++ 
Basomedial amygdaloid nucleus, anterior part (BMA) ++ 
Basomedial amygdaloid nucleus, lateral part (BLA) ++ 
Lateral Amygdaloid Nucleus, Dorsolateral Part (LaDL) ++ 
Lateral Amygdaloid Nucleus, Ventrolateral Part (LaVL) ++ 
Medial Amygdaloid Nucleus Posterodorsal Part (MePD) ++ 
Medial Amygdaloid Nucleus Posteroventral Part (MePV) ++ 
Hippocampal formation  
Granular dentate gyrus (GrDG) +++ 
Pyramidal cell hippocampus (Py) +++  
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Cingulated cortex area 2 (Cg2) +++ 
Indusium griseum (IG) ++ 
Lateral septal nucleus, dorsal part (LSD) ++ 
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